Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim(Stanford Medicine), M. Bagot(Inserm), Lauren Pinter‐Brown(University of California, Irvine), Alain H. Rook(University of Pennsylvania), Pierluigi Porcu(Thomas Jefferson University), Sarah McCue Horwitz(Memorial Sloan Kettering Cancer Center), Sean Whittaker(St Thomas' Hospital), Y. Tokura(Hamamatsu University School of Medicine), Maarten H. Vermeer(Leiden University), Pier Luigi Zinzani(University of Bologna), Lubomir Sokol(Moffitt Cancer Center), Stephen Morris(St Thomas' Hospital), Ellen J. Kim(University of Pennsylvania), Pablo L. Ortiz‐Romero, Herbert Eradat(UCLA Medical Center), Julia Scarisbrick(NIHR Surgical Reconstruction and Microbiology Research Centre), Athanasios Tsianakas(University Hospital Münster), Craig A. Elmets(University of Alabama at Birmingham), Stéphane Dalle(Université Claude Bernard Lyon 1), David C. Fisher(Dana-Farber Cancer Institute), Ahmad Halwani(University of Utah), Brian Poligone(Lymphoma Research Foundation), John P. Greer(Vanderbilt University Medical Center), Maria Teresa Fierro(University of Turin), Amit Khot(Peter MacCallum Cancer Centre), Alison J. Moskowitz(Memorial Sloan Kettering Cancer Center), Amy Musiek(Washington University in St. Louis), Andrei R. Shustov(University of Washington), Barbara Pro(Northwestern University), Larisa J. Geskin(Columbia University Irving Medical Center), Karen M. Dwyer(Kirin (United States)), Junji Moriya(Kirin (United States)), Mollie Leoni(Kirin (United States)), Jeffrey S. Humphrey(Kirin (United States)), Stacie Hudgens(Clinical Solutions), Dmitri O. Grebennik(Kirin (United States)), Kensei Tobinai(National Cancer Center Hospital East), Madeleine Duvic(The University of Texas MD Anderson Cancer Center), Sunil Abhyankar, Oleg E. Akilov, Önder Alpdoğan, M. Beylot‐Barry, Erin Boh, Dolores Caballero, Richard Cowan, Brigitte Dréno, Reinhard Dummer, Timothy S. Fenske, Francine Foss, Noriko Fukuhara, Pratyush Giri, Koji Habe, Toshihisa Hamada, Kiyohiko Hatake, Shinsuke Iida, Osamu Ishikawa, Lars Iversen, Eiji Kiyohara, Hiroshi Koga, Neil J. Korman, Bryone J. Kuss, Zanetta S. Lamar, Frederick Lansigan, Mary Jo Lechowicz, Adam Lerner, Nina Magnolo, Lawrence A. Mark, Tomomitsu Miyagaki, Javier Muñoz, Jan P. Nicolay, Kaoru Nishiwaki, Hiroyuki Okamoto, Mikio Ohtsuka, Theresa Pacheco, Christiane Querfeld, Ronald Peter Rapini, Shigetoshi Sano, Maiko Tanaka, Michael D. Tharp, Jiro Uehara, Hidefumi Wada, Jillian Wells, Ryan A. Wilcox, Basem M. William, Kentaro Yonekura
The Lancet Oncology
August 9, 2018
Cited by 641Open Access
Full Text

Abstract


Related Papers